Organogenesis Holdings Inc. cotiza a 1.21 USD y tiene una capitalización bursátil de $156M. En los últimos 12 meses ha facturado $457M con un margen de flujo de caja libre del -4.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.69 | $-0.34 | $0.40 |
| Estimado | $-0.17 | $-0.35 | $-0.29 | $0.21 |
| Sorpresa | — | -97.1% | -17.2% | +90.5% |
| Métrica | ORGO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 7.9% | -38.6% | +46.5% |
| Net Margin | 6.6% | -33.6% | +40.1% |
| FCF Margin | -4.3% | -13.9% | +9.5% |
| ROE | 12.3% | -40.4% | +52.7% |
| ROA | 6.2% | -32.0% | +38.2% |
| Current Ratio | 3.62 | 2.84 | +0.78 |
| Debt / Equity | — | 0.28 | — |